The convergent syntheses of 3‐deazapurine 2′‐deoxy‐β‐D‐ribonucleosides and 2′,3′‐dideoxy‐D‐ribonucleosides, including 3‐deaza‐2′‐deoxyadenosine (1a) and 3‐deaza‐2′,3′‐dideoxyadenosine (1b) is described. The 4‐chloro‐lH‐imidazo[4,5‐c]pyridinyl anion derived from 5 was reacted with either 2′‐deoxyhalogenose 6 or 2′,3′‐dideoxyhalogenose 10 yielding two regioisomeric (N1 and N3) glycosylation products. They were deprotected and converted into 4‐substituted imidazo[4,5‐c]pyridine 2′‐deoxy‐β‐D‐ribonucleosides and 2′,3′‐dideoxy‐D‐ribonucleosides. Compounds 1a and 1b proved to be more stable against proton‐catalyzed N‐glycosylic bond hydrolysis than the parent purine nucleosides and were not deaminated by adenosine deaminase.
No takes yet. Share an insight, caveat, or question.
Seela et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: